Non-Invasive Evaluation of NAFLD Severity

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are a leading cause of liver diseases worldwide, including hepatocellular carcinoma (HCC). In this review on non-invasive evaluation, Prof. Jérôme Boursier, France, presents a meta analysis focusing on the identification of patients with high risk profile and in need of specific management. Dr. Boursier reviews the two major families of non-invasive tests and discusses the sequential use of tests recommended in the EASL guidelines 2021.
Play Video

Would you like to read more?

Prof. Jérôme Boursier

Prof. Jérôme Boursier

Video SERIES

SUBSCRIBE & FOLLOW US

Subscribe Our Newsletter To Get the Lastest Updates